Skip to main content
Not Found
Digital Seminar

Infectious Diseases: Reduce, Eliminate, Prevent

William Barry Inman, BA-BS, CIC
5 Hours 54 Minutes
Audio and Video
Oct 13, 2016
Product Code:
Media Type:
Digital Seminar - Also available: Digital Seminar | DVD


  • EBOLA: What’s New, What’s True & What’s Next
  • CRE – The new “Nightmare Bug”
  • Serogroup B Vaccine – Meningococcal Disease a Thing of the Past
  • Eradicate HIV
  • New Testing & Treatment for TB
  • New Reporting Requirements for the National Healthcare Safety Network
  • Updates for Healthcare-Associated Infections

Open any newspaper or watch the daily news and you will find the next infectious disease scare. Infectious diseases have been called the terrorists of the natural world. As a healthcare provider you play a critical role in preventing the spread of infection.

Patients and families depend on you to provide them with the most up-to-date information and the best possible care. Controlling infectious disease is one of the most fundamentally important aspects of healthcare. Join nationally-recognized expert, author and epidemiologist, William “Barry” Inman, for this cutting-edge seminar.

Barry regularly works with the CDC and will share his first-hand knowledge of infectious disease, prevention strategies, and the newest treatment break-throughs. Barry will teach you essential strategies to protect patients and staff from resistant microorganisms, reemerging vaccine-preventable diseases, and new infectious threats. You will leave this seminar knowing proper precautions, disease management and the new required reporting guidelines.


National Healthcare Safety Network

  • New requirements from CMS
  • Health-care Associated Infections what to report to the CDC

Compendium Strategies: Critical Updates

  • Catheter-Associated Urinary Tract Infections
  • Surgical Site Infections
  • Ventilator Associated Pneumonias
  • Central-Line Associated Bloodstream Infections
  • Influenza Outbreaks in Healthcare

CDC, APIC, SHEA, IDSA Guidelines to Control Multi-Drug Resistant Organisms

  • CRE: Carbapenem-Resistant Enterobacteriaceae
    • The Nightmare Bug
    • “Very” Resistant-Dangerous Klebisella and E. Coli
    • Death rate of 50-60%
  • C Diff: Clostridium Difficule
    • Epidemiology
    • New Treatments-cure 90%
      • Microbiota
  • MRSA: Methicillin-Resistant Staphlococcus Aureus
    • Community or Healthcare Associated
    • Decolonization of MRSA
  • VRE: Vancomycin Resistant Enterococcus
    • Daptomycin Resistant Enterococcus
  • ESBL:  Extended Spectrum Beta-Lactamase Organisms
    • Resistant Klebisella and E. Coli

EBOLA: What’s New, What’s True & What’s Next

  • Probable Reservoir & Epizootic Cycle
    • Bats
    • Non-Human Primates
    • Duikers
  • Prior Outbreaks of Ebola in Africa
    • Sudan (1976 & 1979 & 2005)
    • Kikwit, Congo (1995)
    • Gabon (1994-1996)
    • Uganda (2000-2001 & 2007-2008)
    • DRC (2007)
  • Symptoms of Ebola
    • Fever
    • Myalgia
    • Malaise
    • Vomiting/Diarrhea
    • Abdominal Pain
    • Unexplained Hemorrhage
  • Transmission of Ebola
    • Bodily Fluids
    • Cultural Rituals
  • Possible Treatments for Ebola
    • Supportive
    • Mono-clonal Antibodies 
  • Appropriate Infection Control Protocols
    • PPEs
    • During Aerosol-Generating Procedures
    • Hand-washing and Disinfectants 
  • Appropriate laboratory tests
    • PCR
    • IgM
  • Protocol for Testing for Ebola
    • Appropriate Risks
    • CDC (Centers for Disease Control)

Emerging Infectious Diseases: Exotic to the Common

  • Meningococcal Disease
    • Bacterial, Fungal & Viral Meningitis
    • New Vaccines for Serogroup B
    • Could be a disease of the past
  • Dengue Fever and Chikungunya
    • New threat to USA
  • Tickborne Diseases
    • Lyme
    • Ehrichioses
    • Babesiosis
    • Rocky Mountain Spotted Fever

Managing Foodborne Illnesses

  • E. Coli O157-H7
  • Salmonella
  • Listeria
  • Campylobacter
  • Vibrio
  • Norovirus

Vaccine Preventable Diseases are Back!

  • Pertussis (Whooping cough)
  • Measles
  • Controlling Outbreaks

Influenza Information

  • Current Vaccine
  • Treatments
  • Prophylaxis
  • Infection Control Protocols
  • Seasonal vs Pandemics (H1N1)

Pneumococcal Disease

  • New Vaccine for Adults
  • New Protocols
  • PPSV-23 & PCV-13
    • Need both if ≥ 65 years

Updates & New Protocols for Bloodborne Pathogens

  • Hepatitis B:
    • Protocols for Immunizations
      • Healthcare Personnel
      • Children-Adolescents
      • Diabetics
    • Approved Treatments for Chronic Hepatitis B
    • Outbreaks of Hepatitis B and C in Healthcare
  • Hepatitis C:
    • Risk Groups and Factors
    • New Treatment
      • No more Interferon
    • One pill for 12 weeks
    • 95-100% Cure Rate
    • Now a Confirmed Cured Patient”
      • The Science Behind the Cure
    • New Treatment: One Pill a Day
    • Prophylaxis for High Risk Groups
    • The Strategy to Eradicate HIV-AIDS
  • Tuberculosis:
    • Blood Test vs Skin Testing
      • IGRA (Interferon Gamma Release Assays)
    • New Treatment Protocols
      • New Prophylaxis Regimen
      • Three Months vs Nine Months
    • Infection Control Protocols for TB


  • Summarize the key components of an effective Infection control program.
  • Interpret the Centers for Disease Control (CDC), Association of Preventionist in Infection Control (APIC), Society of Hospital Epidemiologist (SHEA) and the Infectious Disease Society Association (IDSA) guidelines to control-prevent Health-care Associated Infections such as Influenza, Norovirus, Ventilator-Associated Pneumonia, Catheter Associated Blood-stream infections, catheter associated urinary tract infections and Surgical site infections.
  • Identify typical symptoms of Ebola.
  • Explain transmission routes and the potential treatments for Ebola.
  • Examine appropriate surveillance protocols to detect Health-care associated infections.
  • Describe the extent and control of drug resistant microorganisms such as MRSA, VRE, ESBL, CRE, and C. difficule.
  • Specify the latest vaccine available for healthcare personnel, children-adolescents, and adults.
  • Summarize recent standards by OSHA regarding post exposure prophylaxis and the use of rapid HIV testing methodologies.
  • Discuss appropriate management-control of Influenza for patients, and healthcare facilities.
  • Differentiate between seasonal and pandemic influenza.
  • Discuss and classify the treatment and symptoms of food-borne illness.
  • Discuss to treatment protocols of bloodborne pathogens.


To order the book, Infection Control: Emerging Infectious Diseases, please visit our product store.

To order the book, Laboratory Tests Made Easy, please visit our product store.

Target Audience

Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Respiratory Therapists


ADA Needs

We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.


Satisfaction Guarantee

Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.


* Credit Note - **

NOTE: Tuition includes one free CE Certificate (participant will be able to print the certificate of completion after completing the on-line post-test (80% passing score) and completing the evaluation). 

Continuing Education Information:  Listed below are the continuing education credit(s) currently available for this non-interactive self-study package. Please note, your state licensing board dictates whether self-study is an acceptable form of continuing education. Please refer to your state rules and regulations. If your profession is not listed, please contact your licensing board to determine your continuing education requirements and check for reciprocal approval. For other credit inquiries not specified below, please contact or 800-844-8260 before the event.

Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of your profession.  As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your profession's standards.  

All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners.  For speaker disclosures, please see the faculty biography.

New York Infectious Diseases

PESI, Inc. provider identification number IC128, is an approved provider who has been authorized to offer the mandated course work in barrier precautions and infection control measures. This entire self-study course qualifies for credit under this requirement.

California Nurses

PESI, Inc. is a provider approved by the California Board of  Registered Nursing, Provider #: 17118 for 6.0 self-study contact hours. 

** You will need to provide your license number to PESI. PESI must have this number on file in order for your hours to be valid.

Florida Nurses

PESI, Inc. is an approved provider by the Florida Board of  Nursing. Provider #: FBN2858. These materials qualify for 6.0 self-study contact hours.

CE Broker

Iowa Nurses

PESI, Inc. is an approved provider by the Iowa Board of Nursing. Provider #: 346. Nurses successfully completing these self-study materials will earn 7.2 self-study contact hours. Please email with your license number, include the title, speaker name and date. PESI must have this number on file in order for your hours to be valid.

Other Professions

This self-study activity qualifies for 6.0 continuing education clock hours as required by many national, state and local licensing boards and professional organizations. Save your activity advertisement and certificate of completion, and contact your own board or organization for specific requirements.



William Barry Inman, BA-BS, CIC's Profile

William Barry Inman, BA-BS, CIC Related seminars and products

William "Barry" Inman has 40 years of experience as an epidemiologist, working for a busy health department in Florida. In his current role, Barry is responsible for control of communicable diseases through surveillance and investigation methods, working directly with the infection control personnel in hospitals, long-term care, acute long-term care, and NASA. He advises concerning appropriate precautions/management strategies and assists infectious disease physicians in the diagnosis of uncommon or exotic diseases by working as a liaison between the Department of Health in Florida and the CDC.

Barry has vast experience in outbreak mitigation and prevention, whether within a healthcare facility, in the community or on a cruise ship. His expertise has been sought for a variety of outbreaks, including: rubella, influenza, legionnaire's disease, measles, pertussis, norovirus and multi-drug resistant microorganism (MRSA, CRE, ESBL). Numerous awards have been bestowed upon Barry for his contributions to minimize the effects of constantly evolving infectious diseases.

Speaker Disclosures:
Financial: William "Barry" Inman has employment relationships with Brevard County Health Department, Circles of Care, Brevard Community College, Circles of Care, and Health First Inc. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: William "Barry" Inman is a member of the Association of Practitioners of Infection Control, the Association of Practitioners of Infection Control Local Chapter 45, and the Florida Practitioners of Infection Control.

Alternate Options

Additional Info

Access for Self-Study (Non-Interactive)

Access never expires for this product.

Target Audience

Nurses, and other Healthcare Professionals


  1. Plan strategies to reduce and eliminate catheter-associated urinary tract infections, surgical site infections, ventilator associated and non-ventilator-associated pneumonias and central-line-associated bloodstream infections.
  2. Assess best practices for treatment and control of multi-drug resistant microorganisms, including MRSA, Clostridium difficile, VRE, ESBL and CRE.
  3. Evaluate the newest vaccine recommendations for healthcare workers and children.
  4. Distinguish between mosquito-borne illnesses of Dengue, Chikungunya, and Zika, which may be a threat to the United States.
  5. Assess the latest treatments available for HIV/AIDS, as well as pre-exposure prophylaxis.
  6. Determine the medications available that "cure" Hepatitis C.
  7. Evaluate the current recommendations to control and treat tuberculosis.



Overall:      4.7

Total Reviews: 3


Tracey S

"Quiz questions written in a confusing manner. Some answers appeared as negative statement and some as positive statement with questions not clearly stated."

Kathleen S

"good information for all healthcare workers"

Venessa F

"Very informative speaker and learning materials."

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of live webcasts and online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

Please wait ...

Back to Top